ClinicalTrials.govpublic full text
Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents
nafld, type 2 diabetes, metabolic syndrome
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 325249
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.